Post by
bronkrdr on Apr 13, 2020 11:46am
JAK Inhibitor
An agreement was signed with NIAID to evaluate its Ollumiant drug as a potential treatment for hospitalized patients diagnosed with CVID-19.
Check out the news annoucement.
Comment by
bronkrdr on Apr 14, 2020 2:32pm
Does any one have any news? I'll handle some gossip.